FolioLanternBeta
ONCBeOne Medicines Ltd.

John Oyler

Chief Executive Officer, Director at BeOne Medicines Ltd., as of Aug 12, 2026Sold $328M of stock in the past 12 months: 99% under a disclosed plan and 1% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
1.02M
shares sold, past 12 months
17
days with sales
$53.0M
largest single day, Jul 16, 2026
1
company filed for

Share of stake sold and shares held at BeOne Medicines Ltd. are not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDec 2025: $30.7M under a disclosed planDecJanFebMarAprMayJun 2026: $3.8M to cover taxesJunJul 2026: $207M under a disclosed plan$207MJulAug 2026: $86.5M under a disclosed planAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
BeOne Medicines Ltd. (ONC)Chief Executive Officer, DirectorFeb 2, 2016Aug 12, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.